Dal Cin Paola, McLaughlin Cynthia
CAMD, Cytogenetics Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Curr Protoc Hum Genet. 2012 Apr;Chapter 10:Unit 10.2.1-15. doi: 10.1002/0471142905.hg1002s73.
Cytogenetic analysis of malignant hematological disease is an important methodology used by clinicians and researchers, as observations of clonal chromosomal abnormalities have been shown to have both diagnostic and prognostic significance. The Basic Protocol describes culture, harvest, and preparation of chromosome spreads from bone marrow aspirates. Three alternate protocols describe adaptations of the Basic Protocol for preparation of specimens from chronic lymphocytic leukemia (CLL) blood/bone marrow, plasma cell disorders, mainly bone marrow multiple myeloma (MM), and "solid" hematological samples including lymph nodes and splenic tissue. The modifications involve slightly different culture and harvest methods that are necessary to assure optimal results.
恶性血液病的细胞遗传学分析是临床医生和研究人员使用的一项重要方法,因为已证明对克隆性染色体异常的观察具有诊断和预后意义。基本方案描述了从骨髓穿刺物中培养、收获和制备染色体涂片的方法。三个替代方案描述了对基本方案的调整,用于从慢性淋巴细胞白血病(CLL)血液/骨髓、浆细胞疾病(主要是骨髓多发性骨髓瘤(MM))以及包括淋巴结和脾组织在内的“实体”血液学样本中制备标本。这些修改涉及略有不同的培养和收获方法,以确保获得最佳结果。